Lawrence Steinman - 17 Oct 2022 Form 4/A - Amendment Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Director
Signature: /s/ Larry Steinman
Issuer symbol: KTTA
Transactions as of: 17 Oct 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 06 Jun 2023, 21:01:06 UTC
Date Of Original Report: 17 Oct 2022
Previous filing: 30 Jun 2022
Next filing: 26 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KTTA	Common Stock						1,282,174	17 Oct 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 17, 2022 (the "Transaction Date"), the Reporting Person filed a Form 4 which misstated the total number of shares of Common Stock beneficially owned by the Reporting Person as of the Transaction Date. The Form 4 inadvertently excluded transactions that were reported on a Form 4 filed by the Reporting Person on June 30, 2022. As reported in this amendment, the Reporting Person beneficially owned 1,282,174 shares of the Issuer's Common Stock as of the Transaction Date.

Content

On October 17, 2022 (the "Transaction Date"), the Reporting Person filed a Form 4 which misstated the total number of shares of Common Stock beneficially owned by the Reporting Person as of the Transaction Date. The Form 4 inadvertently excluded transactions that were reported on a Form 4 filed by the Reporting Person on June 30, 2022. As reported in this amendment, the Reporting Person beneficially owned 1,282,174 shares of the Issuer's Common Stock as of the Transaction Date.